Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.45 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.44 |
| ▸ | GPR34 | Q9UPC5 | 2/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5571344 | 0.81 | SMPD1 (0.62) | SMPD1 | |
| SCHEMBL5574626 | 0.81 | SMPD1 (0.62) | SMPD1 | |
| SCHEMBL5573002 | 0.81 | SMPD1 (0.62) | SMPD1 | |
| SCHEMBL5575193 | 0.81 | SMPD1 (0.62) | SMPD1 | |
| SCHEMBL18339529 | 0.81 | SMPD1 (0.62) | SMPD1 | |
| SCHEMBL28746443 | 0.80 | SMPD1 (0.57) | SMPD1NAAALPAR3LPAR1LPAR2 | |
| SCHEMBL460132 | 0.78 | NAAA (0.47) | NAAARAD52NPSR1 | |
| SCHEMBL22915292 | 0.78 | NAAA (0.50) | NAAARAD52NPSR1 | |
| SCHEMBL28565643 | 0.77 | NAAA (0.62) | NAAARAD52NPSR1 | |
| SCHEMBL9295177 | 0.77 | NAAA (0.49) | NAAARAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220265543-A1 | COSMETIC COMPOSITIONS AND USES THEREOF | ALUMIER LABS, INC. (CA) | 2022-08-25 | — | — | US | disclosed |
| EP-4003274-A1 | COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES THEREOF | Alumier Europe Limited (MT) | 2022-06-01 | — | — | EP | disclosed |
| WO-2021013973-A1 | COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES THEREOF | ALUMIER EUROPE LIMITED (MT) | 2021-01-28 | — | — | WO | disclosed |
| EP-2525774-B1 | NEW LIPO-PHOSPHATED OR LIPO-SULPHATED COMPOUND, COMPOSITIONS COMPRISING IT AND TOPICAL USES THEREOF | SEDERMA SA (FR) | 2016-03-30 | — | — | EP | disclosed |
| US-20130004439-A1 | Lipo-Phosphated or Lipo-Sulphated Compound, Compositions Comprising It and Topical Uses Thereof | SEDERMA, S.A.S. (FR) | 2013-01-03 | — | — | US | disclosed |
| US-20130004439-A1 | Lipo-Phosphated or Lipo-Sulphated Compound, Compositions Comprising It and Topical Uses Thereof | SEDERMA, S.A.S. (FR) | 2013-01-03 | — | — | US | disclosed |
| WO-2011086532-A1 | NEW LIPO-PHOSPHATED OR LIPO-SULPHATED COMPOUND, COMPOSITIONS COMPRISING IT AND TOPICAL USES THEREOF | SEDERMA (FR) | 2011-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220265543-A1 | COSMETIC COMPOSITIONS AND USES THEREOF | CUTA, CERS2, GLA | SMPD1 67/4885NAAA 852/4885LPAR3 863/4885 |
| US-20130004439-A1 | Lipo-Phosphated or Lipo-Sulphated Compound, Compositions Comprising It and Topical Uses Thereof | LOXL3, CUTA, LOXL4 | SMPD1 994/4885NAAA 625/4885LPAR3 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.